Rock Springs Capital Management’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,609,492
Closed -$529K 111
2026
Q1
$529K Sell
1,609,492
-1,657,468
-51% -$2.61M 0.03% 97
2025
Q4
$10.1M Hold
3,266,960
0.52% 53
2025
Q3
$8.59M Hold
3,266,960
0.5% 55
2025
Q2
$4.02M Hold
3,266,960
0.25% 68
2025
Q1
$3.59M Hold
3,266,960
0.21% 70
2024
Q4
$2.96M Hold
3,266,960
0.11% 87
2024
Q3
$3.22M Hold
3,266,960
0.1% 92
2024
Q2
$2.94M Hold
3,266,960
0.09% 95
2024
Q1
$3.86M Hold
3,266,960
0.1% 97
2023
Q4
$2.98M Hold
3,266,960
0.07% 91
2023
Q3
$2.72M Buy
3,266,960
+2,166,686
+197% +$2.5M 0.07% 93
2023
Q2
$1.32M Hold
1,100,274
0.03% 112
2023
Q1
$1.39M Buy
1,100,274
+724,226
+193% +$1.39M 0.03% 110
2022
Q4
$816K Sell
376,048
-1,210,914
-76% -$9.97M 0.02% 115
2022
Q3
$19M Buy
+1,586,962
New +$19.7M 0.49% 56

Other funds holding GOSS

Rock Springs Capital Management's GOSS Position: Q2 2026 in Review

Rock Springs Capital Management sold out of Gossamer Bio (GOSS) in Q2 2026, closing a stake of 1,609,492 shares — an estimated $529K sold.

Rock Springs Capital Management first reported a position in GOSS in Q3 2022 and held it in 15 quarters. The position peaked at $19M in Q3 2022. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Rock Springs Capital Management reported no remaining Gossamer Bio position as of Q2 2026 after selling out during the quarter.
  • Rock Springs Capital Management sold 1,609,492 Gossamer Bio shares in Q2 2026, an estimated $529K.
  • Rock Springs Capital Management first reported a position in Gossamer Bio in Q3 2022 and held it in 15 quarters.
  • Rock Springs Capital Management's Gossamer Bio position peaked at $19M in Q3 2022.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Rock Springs Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.